Estrogens can also cause prolactinomas. Especially in the early stages of hormone replacement therapy, blood work is done frequently to assess hormone levels and liver function. Prior to orchiectomy or sex reassignment surgerythe doses of estrogens used in transgender women are often higher than replacement doses used in cisgender women. The risk is higher with oral estrogen transvestite male side affects particularly ethinylestradiol and conjugated estrogens than with injectable, transdermal, implantable, and nasal formulations. Arq Bras Endocrinol Metabol.
Changes caused by these medications can be temporary or permanent. The pelvis retains some masculine characteristics, but the end result of HRT is wider hips than a cisgender man and closer to those of a cisgender woman.
As with any pharmacological or hormone therapy, there are potential side effects, which in the case of transgender hormone therapy include changes in sexual functioning. Injection IM or SC. The evaluation might include:.
Advertising revenue supports our not-for-profit mission. Otherwise, screening can start at age 60 or earlier if sex hormone levels are consistently low.
The nonsteroidal antiandrogens that have been used in transgender women include the first-generation medications flutamide Eulexin , nilutamide Anandron, Nilandron , and bicalutamide Casodex. Hair Loss and Restoration, Second Edition. Monitor for virilizing and adverse effects every 3 months for first year and then every 6 — 12 months.